NEW YORK, April 9, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced the pricing of its underwritten public offering of...
Hence then, the article about lucid diagnostics announces pricing of public offering of common stock was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Lucid Diagnostics Announces Pricing of Public Offering of Common Stock )
Also on site :
- 'Love on the Spectrum' Star Hard Launches New Romance — And Fans Are Shocked by One Trait
- US budget slashing risks losing global scientific edge to China
- LISTEN: ‘Minions and Monsters’ Has Tepid U.S. Opening as ‘Young Washington’ Impresses; Why Comcast’s Sky is Buying ITV